Pharma Patent Strategy in Latin America: Key Developments and What to Expect for 2015
- 05 February 2015
- Articles
Countries of Latin America have a common language, similar culture but in Intellectual Property issues, they are completely different. In this maze of laws and different patent prosecution procedures, Clarke, Modet & Cº will help you to find the most suitable strategy to meet your business goals with time and cost savings.
Who should attend?
Pharmaceutical multinationals, biotechnology and chemical companies with interest in Latin American and Central American countries
Benefits of attending:
– Recommended strategy in the region: key steps to optimize prosecution and accelerate grant with the least number of office actions possible
– From ANVISA in Brazil to new obstrusive Guidelines in Argentina and abusive Official Fees in Ecuador, are we seeing a negative trend or will this change in the coming years?
– Key developments and what to expect in 2015
Twitter
Linkedin
